ESMO-IO SITC Primer & Collaborative Session

ESMO-IO SITC Primer Session & Collaborative Session
In collaboration with the European Society for Medical Oncology (ESMO), the Society for Immunotherapy of Cancer (SITC) presents the ESMO-IO SITC Primer Session and Collaborative Session, which will take place during the ESMO Immuno-Oncology Congress in Geneva, Switzerland on Wednesday, December 6, 2023. 

Target Audience: 
The ESMO Immuno-Oncology Congress will cater to the diverse needs of medical/clinical oncologists, basic translational researchers, oncology nurses, and other oncology stakeholders with an interest in the field of cancer immunotherapy.

Organizers:
Jennifer Guerriero, PhD – Brigham and Women's Hospital 
Aurelien Marabelle, MD, PhD – Gustave Roussy

Primer Session: 
Wednesday, December 6 from 8:30 a.m. – 12:00 p.m. CET
The multisession primer program will provide a foundation for the mechanisms of cancer immunotherapy and explore topics such as tumor immunity, tumor inflammation, myeloid cells, TIL-based therapy, cancer vaccines, and the microbiome influence on the TME. 

Faculty:
George Coukos, MD, PhD – University Hospital of Lausanne
Bernard Fox, PhD – Earle A. Chiles Research Institute
Jennifer Guerriero, PhD – Brigham and Women's Hospital
Ignacio Melero, MD, PhD – Clinica Universidad de Navarra 
Stephen Schoenberger, PhD – La Jolla Institute for Allergy and Immunology 
Laurence Zitvogel, MD – Université de Paris Saclay 

Collaborative Session:
Thursday, December 7 from 14:15 p.m. to 15:45 p.m. CET
The multisession collaborative program will focus on what we have learned about combination therapies and where the field is heading. The agenda includes topics such as lessons learned from combination therapy in Melanoma and GU cancers, deep immunophenotyping to identify biomarkers and therapeutic targets in solid tumors, and biological stratification of patients for better immunotherapy. 

Faculty: 
John Haanen, MD, PhD – Netherlands Cancer Institute, Leiden University Netherlands
Thomas Urban Marron, MD, PhD – Icahn School of Medicine at Mount Sinai
Mathieu Rouanne, MD, PhD – Columbia University

For more information on the ESMO-IO Congress, click below.